671 related articles for article (PubMed ID: 28378293)
21. New obesity agents: lorcaserin and phentermine/topiramate.
Fleming JW; McClendon KS; Riche DM
Ann Pharmacother; 2013; 47(7-8):1007-16. PubMed ID: 23800750
[TBL] [Abstract][Full Text] [Related]
22. A review of the metabolic effects of controlled-release Phentermine/Topiramate.
Kiortsis DN
Hormones (Athens); 2013; 12(4):507-16. PubMed ID: 24457398
[TBL] [Abstract][Full Text] [Related]
23. Pharmacotherapy of obesity: Available medications and drugs under investigation.
Pilitsi E; Farr OM; Polyzos SA; Perakakis N; Nolen-Doerr E; Papathanasiou AE; Mantzoros CS
Metabolism; 2019 Mar; 92():170-192. PubMed ID: 30391259
[TBL] [Abstract][Full Text] [Related]
24. Treatment of obesity in 2015.
Shukla AP; Buniak WI; Aronne LJ
J Cardiopulm Rehabil Prev; 2015; 35(2):81-92. PubMed ID: 25714749
[TBL] [Abstract][Full Text] [Related]
25. Pharmacotherapy for obesity: What you need to know.
Bersoux S; Byun TH; Chaliki SS; Poole KG
Cleve Clin J Med; 2017 Dec; 84(12):951-958. PubMed ID: 29244650
[TBL] [Abstract][Full Text] [Related]
26. The limits and challenges of antiobesity pharmacotherapy.
Gadde KM; Atkins KD
Expert Opin Pharmacother; 2020 Aug; 21(11):1319-1328. PubMed ID: 32292094
[TBL] [Abstract][Full Text] [Related]
27. Pharmacotherapy for Obesity.
Saunders KH; Shukla AP; Igel LI; Kumar RB; Aronne LJ
Endocrinol Metab Clin North Am; 2016 Sep; 45(3):521-38. PubMed ID: 27519128
[TBL] [Abstract][Full Text] [Related]
28. Obesity: Pharmacotherapy.
Powell A
FP Essent; 2020 May; 492():25-29. PubMed ID: 32383845
[TBL] [Abstract][Full Text] [Related]
29. Obesity medications: what does the future look like?
Butsch WS
Curr Opin Endocrinol Diabetes Obes; 2015 Oct; 22(5):360-6. PubMed ID: 26313898
[TBL] [Abstract][Full Text] [Related]
30. Lorcaserin, phentermine topiramate combination, and naltrexone bupropion combination for weight loss: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2014 Dec; 68(12):1401-5. PubMed ID: 25418525
[No Abstract] [Full Text] [Related]
31. Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options.
Andrew CA; Saunders KH; Shukla AP; Aronne LJ
Expert Opin Pharmacother; 2019 Apr; 20(5):585-593. PubMed ID: 30614740
[TBL] [Abstract][Full Text] [Related]
32. Current pharmacotherapies for obesity: A practical perspective.
Golden A
J Am Assoc Nurse Pract; 2017 Oct; 29(S1):S43-S52. PubMed ID: 29024552
[TBL] [Abstract][Full Text] [Related]
33. Tolerability and safety of the new anti-obesity medications.
Hainer V; Aldhoon-Hainerová I
Drug Saf; 2014 Sep; 37(9):693-702. PubMed ID: 25096956
[TBL] [Abstract][Full Text] [Related]
34. Pharmacotherapy for the management of obesity.
Patel D
Metabolism; 2015 Nov; 64(11):1376-85. PubMed ID: 26342499
[TBL] [Abstract][Full Text] [Related]
35. Medical treatment of obesity: the past, the present and the future.
Bray GA
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):665-84. PubMed ID: 25194183
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the Efficacy of Anti-Obesity Medications in Real-World Practice.
Song JE; Ko HJ; Kim AS
Drug Des Devel Ther; 2024; 18():845-858. PubMed ID: 38524878
[TBL] [Abstract][Full Text] [Related]
37. New pharmacological approaches for obesity management.
Rueda-Clausen CF; Padwal RS; Sharma AM
Nat Rev Endocrinol; 2013 Aug; 9(8):467-78. PubMed ID: 23752772
[TBL] [Abstract][Full Text] [Related]
38. Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone/bupropion extended release and phentermine-topiramate extended release.
Halpern B; Mancini MC
Expert Opin Drug Saf; 2017 Jan; 16(1):27-39. PubMed ID: 27732121
[TBL] [Abstract][Full Text] [Related]
39. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
Bays H
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
[TBL] [Abstract][Full Text] [Related]
40. Phentermine and topiramate for the management of obesity: a review.
Cosentino G; Conrad AO; Uwaifo GI
Drug Des Devel Ther; 2013; 7():267-78. PubMed ID: 23630412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
